Terms: = Lymphoma AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Treatment
34 results:
1. Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Watanabe T; Matsuno Y; Wakabayashi M; Maruyama D; Yamamoto K; Kubota N; Shimada K; Asagoe K; Yamaguchi M; Ando K; Ogura M; Kuroda J; Suehiro Y; Tsukasaki K; Tobinai K; Nagai H
Hematol Oncol; 2024 May; 42(3):e3272. PubMed ID: 38595316
[TBL] [Abstract] [Full Text] [Related]
2. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
3. Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for treatment of Pancreatic Cancer: Toward a Universal Chimeric Antigen Receptor T-Cell Strategy for Solid Tumor.
Chen C; Park AK; Monroy I; Ren Y; Kim SI; Chaurasiya S; Priceman SJ; Fong Y
J Am Coll Surg; 2024 Apr; 238(4):436-447. PubMed ID: 38214445
[TBL] [Abstract] [Full Text] [Related]
4. Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database.
Visram A; De La Torre A; White D; Su J; Masih-Khan E; Chu M; Jimenez-Zepeda V; McCurdy A; LeBlanc R; Song K; Mian H; Louzada M; Sebag M; Bergstrom D; Stakiw J; Reiman A; Kotb R; Aslam M; Venner C; Kaedbey R; Gul E; Reece D
Blood Cancer J; 2023 Dec; 13(1):181. PubMed ID: 38065967
[TBL] [Abstract] [Full Text] [Related]
5. Profiling risk factors for separation of infection complications in patients with gastrointestinal and nodal diffuse large B-cell lymphoma.
Xue M; Gao Z; Yan M; Bao Y
BMC Infect Dis; 2023 Oct; 23(1):711. PubMed ID: 37864133
[TBL] [Abstract] [Full Text] [Related]
6. [Interim results of a multicenter cohort study for Chinese Children Leukemia Group-acute lymphoblastic leukemia 2018 regimen].
Chinese Children Leukemia Group
Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):874-880. PubMed ID: 37803853
[No Abstract] [Full Text] [Related]
7. Clinical pathologists should limit modifier terms used to denote probability of a diagnosis: a survey-based study.
Rishniw M; Freeman KP
J Am Vet Med Assoc; 2023 Feb; 261(4):1-8. PubMed ID: 36735507
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry.
Jazmati D; Hero B; Thole-Kliesch TM; Merta J; Deubzer HE; Bäumer C; Heinzelmann F; Schleithoff SS; Koerber F; Eggert A; Schwarz R; Simon T; Timmermann B
Curr Oncol; 2022 Oct; 29(11):8222-8234. PubMed ID: 36354709
[TBL] [Abstract] [Full Text] [Related]
9. A systematic literature review of the epidemiology, quality of life, and economic burden, including disease pathways and treatment patterns of relapsed/refractory classical Hodgkin lymphoma.
Raut M; Singh G; Hiscock I; Sharma S; Pilkhwal N
Expert Rev Hematol; 2022 Jul; 15(7):607-617. PubMed ID: 35794714
[TBL] [Abstract] [Full Text] [Related]
10. Years of life lost to cancer among the United States HIV population, 2006-2015.
Luo Q; Pfeiffer RM; Noone AM; Horner MJ; Engels EA; Shiels MS
AIDS; 2022 Jul; 36(9):1279-1286. PubMed ID: 35608110
[TBL] [Abstract] [Full Text] [Related]
11. Single-centre empirical analysis of double-balloon enteroscopy in the diagnosis and treatment of small bowel diseases: A retrospective study of 466 cases.
Lu L; Yang C; He T; Bai X; Fan M; Yin Y; Wan P; Tang H
Surg Endosc; 2022 Oct; 36(10):7503-7510. PubMed ID: 35286470
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma.
Guan J; Sun F; Wang J; Huang J; Lu S; Zhu J; Zhu X; Huang H; Xia Z; Que Y; Cai R; Zhen Z; Sun X; Zhang Y
Ann Hematol; 2022 Apr; 101(4):763-771. PubMed ID: 34997277
[TBL] [Abstract] [Full Text] [Related]
13. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.
Mauz-Körholz C; Landman-Parker J; Balwierz W; Ammann RA; Anderson RA; Attarbaschi A; Bartelt JM; Beishuizen A; Boudjemaa S; Cepelova M; Claviez A; Daw S; Dieckmann K; Fernández-Teijeiro A; Fosså A; Gattenlöhner S; Georgi T; Hjalgrim LL; Hraskova A; Karlén J; Kluge R; Kurch L; Leblanc T; Mann G; Montravers F; Pears J; Pelz T; Rajić V; Ramsay AD; Stoevesandt D; Uyttebroeck A; Vordermark D; Körholz D; Hasenclever D; Wallace WH
Lancet Oncol; 2022 Jan; 23(1):125-137. PubMed ID: 34895479
[TBL] [Abstract] [Full Text] [Related]
14. New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation.
Dalla Via V; Halter JP; Gerull S; Arranto C; Tichelli A; Heim D; Passweg JR; Medinger M; Cesana-Nigro N
In Vivo; 2020; 34(6):3545-3549. PubMed ID: 33144466
[TBL] [Abstract] [Full Text] [Related]
15. Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia.
Ueno H; Yoshida K; Shiozawa Y; Nannya Y; Iijima-Yamashita Y; Kiyokawa N; Shiraishi Y; Chiba K; Tanaka H; Isobe T; Seki M; Kimura S; Makishima H; Nakagawa MM; Kakiuchi N; Kataoka K; Yoshizato T; Nishijima D; Deguchi T; Ohki K; Sato A; Takahashi H; Hashii Y; Tokimasa S; Hara J; Kosaka Y; Kato K; Inukai T; Takita J; Imamura T; Miyano S; Manabe A; Horibe K; Ogawa S; Sanada M
Blood Adv; 2020 Oct; 4(20):5165-5173. PubMed ID: 33095873
[TBL] [Abstract] [Full Text] [Related]
16. Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity.
Rigacci L; Annibali O; Kovalchuk S; Bonifacio E; Pregnolato F; Angrilli F; Vitolo U; Pozzi S; Broggi S; Luminari S; Merli F; Spina M; Bolis S; Margiotta-Casaluci G; Scalzulli R; Cox C; Mamusa AM; Santoro A; Zinzani PL; Ferrari S; Gini G; Vigliotti ML; Mulè A; Flenghi L;
Hematol Oncol; 2020 Oct; 38(4):478-486. PubMed ID: 32542788
[TBL] [Abstract] [Full Text] [Related]
17. Impact of transitioning inpatient chemotherapy regimens to the outpatient setting.
Corsi MP; Shea K; W Knoebel R
J Oncol Pharm Pract; 2020 Sep; 26(6):1324-1330. PubMed ID: 31822200
[TBL] [Abstract] [Full Text] [Related]
18. Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis.
Tremblay D; King A; Li L; Moshier E; Coltoff A; Koshy A; Kremyanskaya M; Hoffman R; Mauro MJ; Rampal RK; Mascarenhas J
Leuk Lymphoma; 2020 Mar; 61(3):660-667. PubMed ID: 31711337
[TBL] [Abstract] [Full Text] [Related]
19. [Efficacy of RCDOP regimen in the treatment of patients with diffuse large B-cell lymphoma].
Cao YW; Shi Q; Zhang MC; Xu PP; Chen S; Zhao WL; Wang L
Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):485-490. PubMed ID: 30032566
[No Abstract] [Full Text] [Related]
20. Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.
Morton LM; Sampson JN; Armstrong GT; Chen TH; Hudson MM; Karlins E; Dagnall CL; Li SA; Wilson CL; Srivastava DK; Liu W; Kang G; Oeffinger KC; Henderson TO; Moskowitz CS; Gibson TM; Merino DM; Wong JR; Hammond S; Neglia JP; Turcotte LM; Miller J; Bowen L; Wheeler WA; Leisenring WM; Whitton JA; Burdette L; Chung C; Hicks BD; Jones K; Machiela MJ; Vogt A; Wang Z; Yeager M; Neale G; Lear M; Strong LC; Yasui Y; Stovall M; Weathers RE; Smith SA; Howell R; Davies SM; Radloff GA; Onel K; Berrington de González A; Inskip PD; Rajaraman P; Fraumeni JF; Bhatia S; Chanock SJ; Tucker MA; Robison LL
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059430
[TBL] [Abstract] [Full Text] [Related]
[Next]
